RCT of ACP for Transplant

Withdrawn

• Conditions: Cancer Patients Undergoing Stem Cell Transplantation (RCT of ACP for Transplant)
• Interventions: Other: Surveys

• Registration Number: NCT03158467
• Lead Sponsor: Abramson Cancer Center at Penn Medicine

Brief Summary

We aim to examine the effect of an online advance directive on decisional conflict and quality of life in patients undergoing stem cell transplant. We also aim to assess the effect of palliative care at the time of a sentinel event on quality of life.

Detailed Description

Not available

Study Timeline

• Study Start: 2017-05-15
• Study First Submitted: 2017-05-16
• Study First Submitted QC: 2017-05-16
• Study First Posted: 2017-05-18
• Status Verified: 2018-05
• Last Update Submitted: 2018-09-18
• Last Update Posted: 2018-09-20
• Primary Completion: 2019-05-15
• Study Completion: 2019-11-15

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

The inclusion criteria for Phase I (primary objective) are as follows:

• Age ≥ 18 years
• Hematologic malignancy diagnosis including any subset of myeloma, lymphoma, leukemia, or myelodysplastic syndrome
• Currently scheduled for autologous or allogeneic transplant at the Hospital of the University of Pennsylvania

The inclusion criteria for Phase II (secondary objective) are as follows:

• Age ≥ 18 years
• Hematologic malignancy diagnosis including any subset of lymphoma, leukemia, or myelodysplastic syndrome
• Received an autologous or allogeneic stem cell transplant at the Hospital of the University of Pennsylvania and experienced a sentinel event of either 1) disease relapse,2) severe (Grade III or IV) graft-versus-host disease, or 3) unplanned hospital admission with length of stay greater than 72 hours.

Exclusion Criteria

The exclusion criteria for Phase I include:

• Inability to read and write English
• Not serving as the primary decision maker for their health-related decisions
• Having a non-hematologic malignancy reason for undergoing transplantation (e.g. aplastic anemia)

The exclusion criteria for Phase II include:

• Not completing participation in Phase I of the study
• Myeloma diagnosis

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Phase 1	Surveys	-
Phase 2	Surveys	-

Primary Outcome Measures

Name	Time	Method
Number of surveys completed	2 years